Prenatal And Newborn Genetic Testing Market Scope And Analysis

Report Code : TIPBT00002550
Category : Biotechnology

No. of Pages : 150

Buy Now

Prenatal and Newborn Genetic Testing Market Scope and Analysis Report by 2031

Buy Now

Prenatal and Newborn Genetic Testing Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 5.72 Billion
Market Size by 2031	US$ 21.44 Billion
Global CAGR (2023 - 2031)	14.5%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Diagnostic Screening By Disease Indication Cystic Fibrosis Sickle Cell Anaemia Down Syndrome Phenylketonuria Other Diseases By End User Hospitals & Clinics Diagnostic Centers Other End Users
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Quest Diagnostics Inc Bio Rad Laboratories Inc Illumina Inc F Hoffmann La Roche Ltd Qiagen PerkinElmer Inc Ravgen Natera Inc Laboratory Corporation of America Holdings

Prenatal and Newborn Genetic Testing Market News and Recent Developments

The prenatal and newborn genetic testing market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for prenatal and newborn genetic testing and strategies:

PerkinElmer Inc. received the US Food and Drug Administration authorization for the marketing of the EONIS SCID-SMA assay kit for in vitro diagnostic (IVD) use by certified laboratories for the simultaneous detection of spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns. This is the first FDA-authorized assay for SMA screening in newborns in the US, and it is part of the company’s broader EONIS Platform. (Source: PerkinElmer Inc., Press Release, 2022)
LifeCell International launched 'Genome-Scope' - a premier Genetic Diagnostic Test for newborns that assesses for thousands of early childhood onset disorders. (Source: LifeCell International Private Limited, Press Release, 2020)

Prenatal and Newborn Genetic Testing Market Report Coverage and Deliverables

The “Prenatal and Newborn Genetic Testing Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope.
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles